I ♥ boobies. They nourish children. They define a woman’s silhouette. And sometimes, they turn toxic.
Family MattersSexuality
breast cancer
Family MattersSexuality
“”
Why Obesity May Not Raise Breast Cancer Risk in Mexican Americans
For a disease as complex as breast cancer, pinpointing its risk factors, genetic or otherwise, is challenging enough. But an intriguing new study suggests that the task may be even harder when ethnicity is thrown into the mix.
Study: More Evidence for the Harms of Hormone Replacement Therapy
In follow-up studies of the women involved in the large federally funded Women’s Health Initiative, researchers found that hormone replacement therapy (HRT) used after menopause not only increased the risk of breast cancer in …
Study: Eating Tofu to Fight Tumors?
Soy may be good for the heart, but if you’re trying to keep the ticker healthy and happen to be a breast cancer patient as well, then it’s not so clear how beneficial soy products may be for you.
Family MattersBreast Cancer
Breast-Feeding after Breast Cancer Is O.K.
Breast-feeding may sound counterintuitive after breast cancer, but new research indicates there’s no reason why survivors shouldn’t nurse a baby — even on the treated breast.
Revisiting the Debate: Mammogram Benefit for Women in Their 40s?
Adding to the ongoing debate over the benefit of screening mammograms, a new study suggests the tests can reduce breast cancer death rates by 26% in women in their 40s.
Another Study Questions the Benefit of Routine Mammograms
When the U.S. Preventive Services Task Force (USPSTF) changed its screening-mammography guidelines last year — recommending against routine annual mammograms for women in their 40s — the announcement met with some resistance. …
The BPA Debate: Bad Reputation and Still No Answers
Bisphenol-A (BPA), the endocrine-disrupting chemical in plastics — and the go-to environmental health villain — has vexed public-health experts for at least a decade. Reams of inconclusive and conflicting studies on the …
FDA panel: Avastin ineffective against breast cancer
In light of clinical trials suggesting no benefit from the medication among breast cancer patients, U.S. Food and Drug Administration advisory panel voted yesterday in favor of withdrawing approval of the cancer drug Avastin (bevacizumab) for treatment of breast cancer. Avastin, which is manufactured by Roche, was originally granted
…
A Blood Test for Cancer?
Any cancer doctor will tell you that the earlier you pick up a tumor, the better your chances are of treating it and getting it under control.
So researchers at the annual meeting of the American Society of Clinical Oncology in Chicago are announcing some welcome news on that front. Scientists at the biotechnology company Chronix …
Moving toward a breast cancer vaccine?
New research in mice may be a first step toward a breast cancer vaccine for humans. The findings, published online Sunday and scheduled to run in the June 10 issue of the journal Nature Medicine, found that mice who were genetically engineered to be at high risk for breast cancer were effectively immunized against the disease after being
…
Court rules against patenting human genes
In a decision that could have broad ramifications for future genetic research and medical practice, United States District Court Judge Robert W. Sweet ruled Monday that patents on two genes linked to ovarian and breast cancer, BRCA-1 and BRCA-2, were invalid. The case brought by a group including the American Civil Liberties Union, the
…